GlobeNewswire 5/27 BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting
GlobeNewswire 5/13 Immatics Announces First Quarter 2025 Financial Results and Business Update
GlobeNewswire 5/12 Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 5/8 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 5/5 BioNTech Announces First Quarter 2025 Financial Results and Corporate Update
GlobeNewswire 5/5 BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer
GlobeNewswire 5/2 Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administrat...
GlobeNewswire 4/24 BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Pr...
GlobeNewswire 4/22 BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025
GlobeNewswire 4/15 Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025
GlobeNewswire 4/8 Myricx Bio Announces Expansion of its Leadership Team to Advance NMTi-ADCs into Clinical Development
GlobeNewswire 3/24 Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Busine...
GlobeNewswire 3/22 Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.
GlobeNewswire 3/10 Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
GlobeNewswire 3/10 BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
GlobeNewswire 2/24 BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March...
GlobeNewswire 2/12 Genmab Publishes 2024 Annual Report
GlobeNewswire 2/3 BioNTech Completes Acquisition of Biotheus
GlobeNewswire 8/30/2024 HOOKIPA Pharma Announces Board of Directors Changes
GlobeNewswire 8/22/2024 Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vacc...
GlobeNewswire 8/19/2024 TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults wit...
GlobeNewswire 8/16/2024 Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...
GlobeNewswire 8/13/2024 Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/8/2024 Genmab Announces Financial Results for the First Half of 2024
GlobeNewswire 8/8/2024 Genmab Updates 2024 Financial Guidance